Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors
George J. Netto, Mahul B. Amin, Daniel M. Berney, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 469-482
Closed Access | Times Cited: 176

Showing 1-25 of 176 citing articles:

Current best practice for bladder cancer: a narrative review of diagnostics and treatments
Éva Compérat, Mahul B. Amin, Richard Cathomas, et al.
The Lancet (2022) Vol. 400, Iss. 10364, pp. 1712-1721
Open Access | Times Cited: 207
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature
Francesco Claps, Arianna Biasatti, Luca Di Gianfrancesco, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4349-4349
Open Access | Times Cited: 15
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group
Ashish M. Kamat, Andrea B. Apolo, M. Babjuk, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 35, pp. 5437-5447
Open Access | Times Cited: 21
Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study
Akinori Minato, Nobuki Furubayashi, Yujiro Nagata, et al.
Current Oncology (2024) Vol. 31, Iss. 2, pp. 862-871
Open Access | Times Cited: 8
Enfortumab vedotin–related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experience
Evangelia Vlachou, Burles A. Johnson, David J. McConkey, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 7
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging
Luigia Vetrone, Riccardo Mei, Lorenzo Bianchi, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1716-1716
Open Access | Times Cited: 18
Unmarried Status Effect on Stage at Presentation and Treatment Patterns in Non-Metastatic Upper Tract Urothelial Carcinoma Patients
Simone Morra, Lukas Scheipner, Andrea Baudo, et al.
Clinical Genitourinary Cancer (2024) Vol. 22, Iss. 4, pp. 102105-102105
Closed Access | Times Cited: 6
Rare histological prostate cancer subtypes: Cancer-specific and other-cause mortality
Carolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
Prostate Cancer and Prostatic Diseases (2024)
Open Access | Times Cited: 6
CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3
Kun Zhong, Wenwu Luo, Nan Li, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 2
Open Access | Times Cited: 5
Regional differences in upper tract urothelial carcinoma patients across the United States
Simone Morra, Lukas Scheipner, Andrea Baudo, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 5, pp. 162.e1-162.e10
Closed Access | Times Cited: 5
Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current Development
Whi‐An Kwon, Ho Kyung Seo, Geehyun Song, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 86-86
Open Access
S100A8 promotes the proliferation, migration and invasion in bladder cancer cells
Haoran Xu, Zhen Pang, Qinzhang Wang, et al.
Journal of Cancer (2025) Vol. 16, Iss. 4, pp. 1066-1077
Open Access
A stacking ensemble system for identifying the presence of histological variants in bladder carcinoma: a multicenter study
Canjie Peng, Quanhao He, Fajin Lv, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Neoadjuvant Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Chemotherapy for Muscle-Invasive Urothelial Cancer: Large, Single-Center Analysis of Consecutive Patients’ Data
Łukasz Kwinta, Kamil Konopka, Krzysztof Okoń, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 258-258
Open Access
AI-based prediction of androgen receptor expression and its prognostic significance in prostate cancer
Jiawei Zhang, Feng Ding, Yitian Guo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Pathological features and immunohistochemical characteristics of clear cell (glycogen-rich) urothelial carcinoma: a case report and systematic review of the literature
Weiming Wang, Baogang Zhang, Zhangli Wu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non‐Muscle Invasive Bladder Cancer
Takahisa Yamashita, Morihiro Higashi, Mami Yamazaki, et al.
Pathology International (2025)
Closed Access
Sarcomatoid areas of urothelial carcinoma are enriched for CD163‐positive antigen‐presenting cells
Burles A. Johnson, Vamsi Parimi, Sonia Kamanda, et al.
The Journal of Pathology Clinical Research (2025) Vol. 11, Iss. 2
Open Access
The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
Shi Yi-fu, Xinyuan Wei, Fengnian Zhao, et al.
The Prostate (2025)
Open Access
Diagnostic workout of glandular malignant lesions of the bladder according to the 5th WHO classification
Francesca Sanguedolce, Angelo Cormio, Magda Zanelli, et al.
Critical Reviews in Clinical Laboratory Sciences (2025), pp. 1-12
Closed Access
Antibody–drug conjugates in rare genitourinary tumors: review and perspectives
Andre Rashad Kydd, Md Shahid Sarwar, Saad Omar Atiq, et al.
Current Opinion in Oncology (2025)
Closed Access
Proteogenomic Characterization of Bladder Cancer Reveals Sensitivity to Apoptosis Induced by Tumor Necrosis Factor–related Apoptosis-inducing Ligand in FGFR3-mutated Tumors
Clarice S. Groeneveld, Virginia Sánchez‐Quiles, Florent Dufour, et al.
European Urology (2023) Vol. 85, Iss. 5, pp. 483-494
Open Access | Times Cited: 14
Cribriform pattern and intraductal carcinoma of the prostate can have a clinicopathological impact, regardless of their percentage and/or number of cores
Yoichiro Okubo, Shinya Sato, Chie Hasegawa, et al.
Human Pathology (2023) Vol. 135, pp. 99-107
Open Access | Times Cited: 12
Progress and application of intelligent nanomedicine in urinary system tumors
Yingming Xiao, Lei Zhong, Jinpeng Liu, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 12, pp. 100964-100964
Open Access | Times Cited: 4
Multimodal Approach in the Diagnosis of Urologic Malignancies: Critical Assessment of ChatGPT-4V's Image-Reading Capabilities
Lingxuan Zhu, Yancheng Lai, Na Ta, et al.
JCO Clinical Cancer Informatics (2024), Iss. 8
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top